MATERNAL PLASMA VISFATIN IN PRETERM LABOR

OBJECTIVE: Visfatin, a novel adipokine with diabetogenic and immunomodulatory properties, has been implicated in the pathophysiology of insulin resistance, as well as in various acute and chronic inflammatory disorders. We have previously reported that amniotic fluid concentrations of visfatin are h...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Matern Fetal Neonatal Med
Päätekijät: MAZAKI-TOVI, SHALI, ROMERO, ROBERTO, VAISBUCH, EDI, EREZ, OFFER, CHAIWORAPONGSA, TINNAKORN, MITTAL, POOJA, KIM, SUN KWON, PACORA, PERCY, GOTSCH, FRANCESCA, DONG, ZHONG, HASSAN, SONIA S., KUSANOVIC, JUAN PEDRO
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656365/
https://ncbi.nlm.nih.gov/pubmed/19572235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14767050902994788
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia